Skip to main content
SpringerLink
Log in

Oesophageal Mucosal Diseases in the Elderly

  • Review Article
  • Disease Management
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Diseases of the oesophageal mucosa are particularly prevalent in the elderly population and may present with various symptoms, such as heartburn, dysphagia or chest pain. Recent technological advances, such as endoscopy, ambulatory pH monitoring and radiological imaging, have allowed for a more accurate diagnosis and assessment of disease severity. Depending on the leading presenting symptom, empirical medical therapy or stepwise diagnostic tests may be used. Elderly patients with mild reflux symptoms respond well to over-the-counter antacids, acid suppressants or prescription prokinetic drugs. Those with more severe gastrooesophageal reflux disease and Barrett’s oesophagus benefit from powerful acid suppressive therapy to relieve symptoms, heal the mucosal damage and prevent complications. Long term, cost-effective pharmacological therapies are constantly being defined.

Because of the widespread utilisation of medications in the elderly, drug-induced oesophageal injury should always be considered and prevented. An increasing number of immunocompromised elderly patients are diagnosed and successfully treated for infectious oesophagitis. Overall, for most elderly patients, when the diagnosis is made correctly, modern medical and/or surgical treatments yield maximal therapeutic benefit and improve quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. National Institutes of Health. Digestive diseases in the US: epidemiology and impact. Bethesda (MD): US Department of Health and Human Services, National Institutes of Health, 1994

    Google Scholar 

  2. Castell DO. Esophageal disorders in the elderly. Gastroenterol Clin North Am 1990; 19: 235–44

    PubMed  CAS  Google Scholar 

  3. Raiha I, Impivaara O, Seppala M, et al. Prevalence and characteristics of symptomatic gastroesophageal reflux disease in the aged. J Am Geriatr Soc 1992; 50: 1209–11

    Google Scholar 

  4. Collen MJ, Abdulian JD, Chen YK. Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy. Am J Gastroenterol 1995; 90: 1053–7

    PubMed  CAS  Google Scholar 

  5. Castell DO, Donner MW. Evaluation of dysphagia: a careful history is crucial. Dysphagia 1987; 2: 65–71

    Article  PubMed  CAS  Google Scholar 

  6. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastroesophageal reflux disease. Lancet 1990; 335: 205–8

    Article  PubMed  CAS  Google Scholar 

  7. Davies HA, Page Z, Rush EM, et al. Esophageal stimulation lowers angina threshold. Lancet 1985; I: 1011–3

    Article  Google Scholar 

  8. Raiha IJ, Ivaska K, Sourander LB. Pulmonary function in gastroesophageal reflux disease of elderly people. Age Ageing 1992; 21: 368–73

    Article  PubMed  CAS  Google Scholar 

  9. Zhu H, Pace F, Sangaletti O, et al. Features of symptomatic gastroesophageal reflux in elderly patients. Scand J Gastroenterol 1993; 28: 235–8

    Article  PubMed  CAS  Google Scholar 

  10. Mold JW, Rankin RA. Symptomatic gastroesophageal reflux in the elderly. J Am Geriatr Soc 1987; 35: 649–59

    PubMed  CAS  Google Scholar 

  11. Raiha IJ, Heitanen E, Sourander LB. Symptoms of gastroesophageal reflux disease in elderly people. Age Ageing 1991; 20: 365–70

    Article  PubMed  CAS  Google Scholar 

  12. Kozarek RA. Complications of reflux esophagitis and their medical management. Gastroenterol Clin North Am 1990; 19: 713–31

    PubMed  CAS  Google Scholar 

  13. Pope II CE. Acid-reflux disorders. N Engl J Med 1994; 331: 656–60

    Article  PubMed  Google Scholar 

  14. Collen MJ, Abdulian JD, Chen YK. Age does not affect basal gastric acid secretion in normal subjects and acid-peptic disease. Am J Gastroenterol 1994; 89: 712–6

    PubMed  CAS  Google Scholar 

  15. Goldschmeidt M, Barnett CC, Schwarz BE, et al. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991; 101: 977–90

    Google Scholar 

  16. Hollis JB, Castell DO. Esophageal function in elderly men: a new look at ‘presbyesophagus’. Ann Intern Med 1974; 80: 371–4

    PubMed  CAS  Google Scholar 

  17. Tibbling L. Gastroesophageal reflux disease and NSAIDs. Scand J Gastroenterol 1987; 84: 236–8

    Google Scholar 

  18. Lasch H, Castell DO, Castell JA. Evidence for diminished visceral pain with aging: studies using graded intraesophageal balloon distention. Am J Physiol 1997; 272: G1–3

    PubMed  CAS  Google Scholar 

  19. Mittal RK, Balaban DH. Mechanisms of gastroesophageal reflux. N Engl J Med 1997; 336: 924–31

    Article  PubMed  CAS  Google Scholar 

  20. Kahrilas PJ, Dodds WJ, Hogan WJ, et al. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 1986; 91: 897–904

    PubMed  CAS  Google Scholar 

  21. Kahrilas PJ, Gupta RR. The effect of cigarette smoking on salivation and esophageal clearance. J Lab Clin Med 1989; 114: 418–21

    Google Scholar 

  22. Helms JF, Dodds WJ, Hogan WJ. Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterology 1987; 93: 393–7

    Google Scholar 

  23. Morton LS, Fromkes JJ. Gastroesophageal reflux disease: diagnostic and medical therapy. Geriatrics 1993; 48: 60–6

    PubMed  CAS  Google Scholar 

  24. Segal WN, Cello JP. Hemorrhage in upper gastrointestinal tract in the older patient. Am J Gastroenterol 1997; 92: 42–6

    PubMed  CAS  Google Scholar 

  25. Pearlman NW, Stiegmann GV, Teter A. Primary upper aero-digestive tract manifestations of gastroesophageal reflux. Am J Gastroenterol 1988; 83: 22–5

    PubMed  CAS  Google Scholar 

  26. Kitchin LI, Castell DO. Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Arch Intern Med 1991; 151: 448–54

    Article  PubMed  CAS  Google Scholar 

  27. Ramirez B, Richter JE. Promotility drugs in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther 1993; 7: 5–20

    Article  PubMed  CAS  Google Scholar 

  28. Lepoutre I, van der Spek P, Vanderlinden I, et al. Healing of grade II and grade III esophagitis through motility stimulation with cisapride. Digestion 1990; 45: 109–14

    Article  PubMed  CAS  Google Scholar 

  29. Janisch HD, Hutterman W, Bouzo MH. Cisapride versus ranitidine in the treatment of reflux esophagitis. Hepatogastroenterology 1988; 35: 125–7

    PubMed  CAS  Google Scholar 

  30. Sontag SJ. The medical management of reflux esophagitis: role of antacids and acid inhibition. Gastroenterol Clin North Am 1990; 19: 683–712

    PubMed  CAS  Google Scholar 

  31. Euler AR, Murdock RH, Wilson TH, et al. Ranitidine is effective therapy for erosive esophagitis. Am J Gastroenterol 1993; 88: 520–4

    PubMed  CAS  Google Scholar 

  32. Wesdorp ICE, Dekker W, Festen HPM. Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis. Dig Dis Sci 1993; 38: 2287–93

    Article  PubMed  CAS  Google Scholar 

  33. Orlando RC. Sucralfate therapy and reflux esophagitis: an overview. Am J Med 1991; 91Suppl. 2A: 123S–4S

    Article  PubMed  CAS  Google Scholar 

  34. Feldman M, Harford WB, Fisher RS, et al. Treatment of reflux esophagitis resistant to H2 receptor antagonists with lansoprazole, a new H/K-ATPase inhibitor: a controlled, double-blind study. Am J Gastroenterol 1993; 88: 1212–7

    PubMed  CAS  Google Scholar 

  35. Bianchi Porro G, Pace F, Peracchia A, et al. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine. J Clin Gastroenterol 1992; 15: 192–8

    Article  PubMed  CAS  Google Scholar 

  36. Smith PM, Kerr GD, Cockel R, et al. A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Gastroenterology 1994; 107: 1312–8

    PubMed  CAS  Google Scholar 

  37. Herzel DJ, Dent J, Reed WD, et al. Healing and relapses of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–12

    Google Scholar 

  38. Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995; 333: 1106–10

    Article  PubMed  CAS  Google Scholar 

  39. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, et al. Long term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994; 121: 161–7

    PubMed  CAS  Google Scholar 

  40. Koop H, Arnold R. Long-term maintenance therapy of reflux esophagitis on omeprazole. Dig Dis Sci 1991; 36: 552–7

    Article  PubMed  CAS  Google Scholar 

  41. Allen R, Rappaport W, Hixson L, et al. Referral patterns and the results of antireflux operations in patients with more than sixty years of age. Surg Gynecol Obstet 1991; 173: 359–62

    PubMed  CAS  Google Scholar 

  42. Luostarinen M, Isolauri J, Laitinen J, et al. Fate of Nissen fundoplication after 20 years: a clinical, endoscopical, and functional analysis. Gut 1993; 34: 1015–20

    Article  PubMed  CAS  Google Scholar 

  43. Richter JE. Why does surgery work for GERD? Practical Gastroenterol 1994; 17: 10–8

    Google Scholar 

  44. Spechler SJ, Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 1992; 326: 786–92

    Article  PubMed  CAS  Google Scholar 

  45. Spechler SJ. Barrett’s esophagus. Semin Oncol 1994; 21: 431–7

    PubMed  CAS  Google Scholar 

  46. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and the esophagogastric junction. Gastroenterology 1993; 104: 510–3

    PubMed  CAS  Google Scholar 

  47. Winter Jr C, Spurling TJ, Chobanian SJ, et al. Barrett’s esophagus: a prevalent occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118–24

    Google Scholar 

  48. Johnson DA, Winters C, Spurling TJ, et al. Esophageal acid sensitivity in Barrett’s esophagus. J Clin Gastroenterol 1987; 9: 23–7

    Article  PubMed  CAS  Google Scholar 

  49. Cameron AJ, Lomboy CT. Barrett’s esophagus: age, prevalence and extent of columnar epithelium. Gastroenterology 1992; 103: 1241–5

    PubMed  CAS  Google Scholar 

  50. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology 1993; 105: 40–50

    PubMed  CAS  Google Scholar 

  51. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110: 614–21

    Article  PubMed  CAS  Google Scholar 

  52. Lightdale CJ. Photodynamic therapy: a new light on Barrett’s esophagus. Gastrointest Endosc 1995; 42: 96–8

    Article  PubMed  CAS  Google Scholar 

  53. Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett’s esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 1996; 44: 532–5

    Article  PubMed  CAS  Google Scholar 

  54. Overholt B, Panjehpour M, Teftellar E, et al. Photodynamic therapy for treatment of early adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc 1993; 39: 73–6

    Article  PubMed  CAS  Google Scholar 

  55. Spechler SJ. Laser photocoagulation of Barrett’s epithelium: burning issues about burning tissues. Gastroenterology 1993; 104: 1855–8

    PubMed  CAS  Google Scholar 

  56. Sampliner RF, Fennerty MB, Garewal HS. Reversal of Barrett’s esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 1996; 44: 523–5

    Article  Google Scholar 

  57. Dorman DB, Ginsberg AL. The hazard of drug-induced esophagitis. Hosp Pract 1981; 16: 17–25

    Google Scholar 

  58. Hey H, Jorgensen F, Sorenson K, et al. Oesophageal transit of six commonly used tablets and capsules. BMJ 1989; 285: 1717–8

    Article  Google Scholar 

  59. El-Serag H, Sonnenberg A. Association of esophagitis and esophageal strictures with diseases treated with NSAIDs. Am J Gastroenterol 1997; 92: 52–6

    PubMed  CAS  Google Scholar 

  60. Bott S, Prakash C, McCallum RW. Medication-induced esophageal injury: survey of the literature. Am J Gastroenterol 1987; 82: 758–63

    PubMed  CAS  Google Scholar 

  61. de Groen PC, Lubbe DF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med 1996; 335: 1016–21

    Article  PubMed  Google Scholar 

  62. McCord GS, Clouse RE. Pill-induced esophageal strictures: clinical features and risk factors for development. Am J Med 1990; 88: 512–8

    Article  PubMed  CAS  Google Scholar 

  63. Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology 1994; 106: 509–32

    PubMed  CAS  Google Scholar 

  64. Laine L, Dretler RH, Conteas C, et al. A prospective, randomized, double-blind trial of fluconazole vs. ketoconazole for Candida esophagitis. Ann Intern Med 1992; 117: 655–60

    PubMed  CAS  Google Scholar 

  65. Paya CV. Fungal infections in solid organ transplantation. Clin Infect Dis 1993; 16: 677–88

    Article  PubMed  CAS  Google Scholar 

  66. Laine L. The natural history of esophageal candidiasis after successful treatment in patients with AIDS. Gastroenterology 1994; 107: 744–6

    Article  PubMed  CAS  Google Scholar 

  67. Byard RW, Champion MC, Orizaga M. Variability in the clinical presentation and endoscopic findings of herpetic esophagitis. Endoscopy 1987; 19: 153–5

    Article  PubMed  CAS  Google Scholar 

  68. Sall RK, Kauffman CL, Levy CS. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome. Arch Dermatol 1989; 125: 1548–50

    Article  PubMed  CAS  Google Scholar 

  69. Goodgame R. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993; 119: 924–35

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Section, Palo Alto Veterans Affairs Health Care System, Palo Alto, USA

    Rodica Ouatu-Lascar &  George Triadafilopoulos

  2. Division of Gastroenterology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA

    Rodica Ouatu-Lascar &  George Triadafilopoulos

Authors
  1. Rodica Ouatu-Lascar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Triadafilopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George Triadafilopoulos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ouatu-Lascar, R., Triadafilopoulos, G. Oesophageal Mucosal Diseases in the Elderly. Drugs Aging 12, 261–276 (1998). https://doi.org/10.2165/00002512-199812040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199812040-00002

Keywords

Search

Navigation